Cangzhou Senary Chemical Science Tech Co Ltd | CAS 915095-94-2 | Related Intermediates | Manufacturers & Suppliers

Also known as: 915095-94-2, (s)-4-iodo-1-chloro-2-(4-tetrahydrofuran-3-yloxy-benzyl)-benzene, (3s)-3-[4-[(2-chloro-5-iodophenyl)methyl]phenoxy]tetrahydro-furan, 3-[4-[(2-chloro-5-iodophenyl)methyl]phenoxy]tetrahydro-furan, (3s)-3-[4-[(2-chloro-5-iodophenyl)methyl]phenoxy]oxolane, (3s)-3-{4-[(2-chloro-5-iodophenyl)methyl]phenoxy}oxolane

Molecular Formula

C₁₇H₁₆ClIO₂

Molecular Weight

414.7 g/mol

InChI Key

YLUHNGIWRCCQMQ-INIZCTEOSA-N

1 2D Structure

CAS 915095-94-2

2 Identification

2.1 Computed Descriptors

2.1.1 IUPAC Name

(3S)-3-[4-[(2-chloro-5-iodophenyl)methyl]phenoxy]oxolane

2.1.2 InChI

InChI=1S/C17H16ClIO2/c18-17-6-3-14(19)10-13(17)9-12-1-4-15(5-2-12)21-16-7-8-20-11-16/h1-6,10,16H,7-9,11H2/t16-/m0/s1

2.1.3 InChI Key

YLUHNGIWRCCQMQ-INIZCTEOSA-N

2.1.4 Canonical SMILES

C1COCC1OC2=CC=C(C=C2)CC3=C(C=CC(=C3)I)Cl

2.1.5 Isomeric SMILES

C1COC[C@H]1OC2=CC=C(C=C2)CC3=C(C=CC(=C3)I)Cl

2.2 Synonyms

2.2.1 Depositor-Supplied Synonyms

1. 915095-94-2

2. (s)-4-iodo-1-chloro-2-(4-tetrahydrofuran-3-yloxy-benzyl)-benzene

3. (3s)-3-[4-[(2-chloro-5-iodophenyl)methyl]phenoxy]tetrahydro-furan

4. 3-[4-[(2-chloro-5-iodophenyl)methyl]phenoxy]tetrahydro-furan

5. (3s)-3-[4-[(2-chloro-5-iodophenyl)methyl]phenoxy]oxolane

6. (3s)-3-{4-[(2-chloro-5-iodophenyl)methyl]phenoxy}oxolane

7. (s)-3-(4-(2-chloro-5-iodobenzyl)phenoxy)-tetrahydrofuran

8. (3s)-3-(4-(2-chloro-5-iodobenzyl)phenoxy)tetrahydrofuran

9. (3s)-3-[4-(2-chloro-5-iodobenzyl)phenoxy]tetrahydrofuran

10. Schembl1647749

11. Dtxsid20893799

12. (s)-3-(4-(2-chlor-5-iod-benzyl)-phenoxy)-tetrahydro-furan

13. Amy16483

14. Bcp11842

15. Mfcd28098707

16. Zinc34775235

17. Akos024462514

18. Ds-9823

19. Cs-0010416

20. P14530

21. A854816

22. (s)-3-[4-(2-chlor-5-iod-benzyl)-phenoxy]tetrahydrofuran

23. (s)-3-(4-(2-chloro-5-iodobenzyl)phenoxy)-tetrahydrofuran;(s)-3-(4-(2-chloro-5-iodobenzyl)phenoxy)tetrahydrofuran

2.3 Create Date

2007-02-21

3 Chemical and Physical Properties

Molecular Formula	C₁₇H₁₆ClIO₂
Molecular Weight	414.7 g/mol
XLogP3	5.1
Hydrogen Bond Donor Count	0
Hydrogen Bond Acceptor Count	2
Rotatable Bond Count	4
Exact Mass	413.98836 g/mol
Monoisotopic Mass	413.98836 g/mol
Topological Polar Surface Area	18.5 Å²
Heavy Atom Count	21
Formal Charge	0
Complexity	320
Isotope Atom Count	0
Defined Atom Stereocenter Count	1
Undefined Atom Stereocenter Count	0
Defined Bond Stereocenter Count	0
Undefined Bond Stereocenter Count	0
Covalently Bonded Unit Count	1

List of Suppliers

Full Screen View

Reset Filter

Ask Us

Cangzhou Senary Chemical Science-te...

Upload your Marketing & Sales content on your company Virtual Booth, click HERE

Post an Enquiry

China

Virtual Booth

Digital Content

2.3.4.6- Tetrakis-O-trimethylsilyl-D-gluconolactone

PDF Supplier PDF

URL Supplier Web Content

CAS Number

32384-65-9

End Use API

Empagliflozin

About the Company

Founded in 2003, Senary Chem is one of the Key High-Tech Enterprises of National Torch Plan. Senary locat...

Founded in 2003, Senary Chem is one of the Key High-Tech Enterprises of National Torch Plan. Senary located in National Cangzhou Lingang Economic and Technological Development Zone,Cangzhou City,Hebei Province. Senary cover an area of 67,000 square meters, and 300 professionals work there. Senary R&D organization recognized as the Hebei Provincial Engineering Technology Center is comprised of two R & D centers in Tianjin and Cangzhou, and it employs 80 experienced scientists in total. Senary focus on the development, production and sales of advanced pharmaceutical intermediates. Especially, Senary has leading technology and manufacturing capacity for diabetes drug intermediates. All intermediates of DPP4 and SGLT2 class drugs on market have been commercialized production. Senary has 150 sets of 50 ~ 8000L reactor with annual production capacity of 1,000 tons, which can handle both low and high temperature reactions within -100 ~ 240 ℃ range, all kinds of catalytic reactions within 0 ~ 5MPa pressure, and moisture and/or oxygen sensitive reactions. Senary also has expertise in chiral synthesis with leading technologies. The advanced sewage treatment system at Senery has processing capacity of 600 tons daily. Senary has an excellent team that has rich quality management experience.We have established a set of normative and perfect quality managment system,monitoring the whole process of risk assessment,R&D,transfer from pilot scale to commercial production,manufacturing,analysis and sales service. Senary will continue to dedicate on the field of pharmaceutical intermediates to provide the best service for domestic and foreign API pharmaceutical companies with high quality and timely supply of products.

ASK
US

Upload
your Marketing & Sales content

Cangzhou Senary Chemical Science-te...

Upload your Marketing & Sales content on your company Virtual Booth, click HERE

Post an Enquiry

China

Virtual Booth

Digital Content

4-((5-bromo-2-chlorophenyl)methyl)phenol

PDF Supplier PDF

URL Supplier Web Content

CAS Number

864070-18-8

End Use API

Empagliflozin

About the Company

Founded in 2003, Senary Chem is one of the Key High-Tech Enterprises of National Torch Plan. Senary locat...

Founded in 2003, Senary Chem is one of the Key High-Tech Enterprises of National Torch Plan. Senary located in National Cangzhou Lingang Economic and Technological Development Zone,Cangzhou City,Hebei Province. Senary cover an area of 67,000 square meters, and 300 professionals work there. Senary R&D organization recognized as the Hebei Provincial Engineering Technology Center is comprised of two R & D centers in Tianjin and Cangzhou, and it employs 80 experienced scientists in total. Senary focus on the development, production and sales of advanced pharmaceutical intermediates. Especially, Senary has leading technology and manufacturing capacity for diabetes drug intermediates. All intermediates of DPP4 and SGLT2 class drugs on market have been commercialized production. Senary has 150 sets of 50 ~ 8000L reactor with annual production capacity of 1,000 tons, which can handle both low and high temperature reactions within -100 ~ 240 ℃ range, all kinds of catalytic reactions within 0 ~ 5MPa pressure, and moisture and/or oxygen sensitive reactions. Senary also has expertise in chiral synthesis with leading technologies. The advanced sewage treatment system at Senery has processing capacity of 600 tons daily. Senary has an excellent team that has rich quality management experience.We have established a set of normative and perfect quality managment system,monitoring the whole process of risk assessment,R&D,transfer from pilot scale to commercial production,manufacturing,analysis and sales service. Senary will continue to dedicate on the field of pharmaceutical intermediates to provide the best service for domestic and foreign API pharmaceutical companies with high quality and timely supply of products.

ASK
US

Upload
your Marketing & Sales content

Cangzhou Senary Chemical Science-te...

Upload your Marketing & Sales content on your company Virtual Booth, click HERE

Post an Enquiry

China

Virtual Booth

Digital Content

(3S)-3[4-[(5-bromo-2-chlorophenyl)methyl]phenoxy]tetrah...

PDF Supplier PDF

URL Supplier Web Content

CAS Number

915095-89-5

End Use API

Empagliflozin

About the Company

Founded in 2003, Senary Chem is one of the Key High-Tech Enterprises of National Torch Plan. Senary locat...

Founded in 2003, Senary Chem is one of the Key High-Tech Enterprises of National Torch Plan. Senary located in National Cangzhou Lingang Economic and Technological Development Zone,Cangzhou City,Hebei Province. Senary cover an area of 67,000 square meters, and 300 professionals work there. Senary R&D organization recognized as the Hebei Provincial Engineering Technology Center is comprised of two R & D centers in Tianjin and Cangzhou, and it employs 80 experienced scientists in total. Senary focus on the development, production and sales of advanced pharmaceutical intermediates. Especially, Senary has leading technology and manufacturing capacity for diabetes drug intermediates. All intermediates of DPP4 and SGLT2 class drugs on market have been commercialized production. Senary has 150 sets of 50 ~ 8000L reactor with annual production capacity of 1,000 tons, which can handle both low and high temperature reactions within -100 ~ 240 ℃ range, all kinds of catalytic reactions within 0 ~ 5MPa pressure, and moisture and/or oxygen sensitive reactions. Senary also has expertise in chiral synthesis with leading technologies. The advanced sewage treatment system at Senery has processing capacity of 600 tons daily. Senary has an excellent team that has rich quality management experience.We have established a set of normative and perfect quality managment system,monitoring the whole process of risk assessment,R&D,transfer from pilot scale to commercial production,manufacturing,analysis and sales service. Senary will continue to dedicate on the field of pharmaceutical intermediates to provide the best service for domestic and foreign API pharmaceutical companies with high quality and timely supply of products.

ASK
US

Upload
your Marketing & Sales content